Influenza Vaccine (Split Virion)，Inactivated，Quadrivalent (Jiangsu Jindike Biotechnology)

四价流感病毒裂解疫苗（江苏金迪克）

Report date: 2025/09/29 17:17:12

Base Information

Drug NameInfluenza Vaccine (Split Virion)，Inactivated，Quadrivalent (Jiangsu Jindike Biotechnology)
Drug Alias Name流行感冒疫苗 - 江苏金迪克生物技术有限公司流行性感冒疫苗 - 江苏金迪克生物技术有限公司流感疫苗 - 江苏金迪克生物技术有限公司迪福赛尔
ClassificationVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[6] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2019/05/21
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Jindike Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Jindike Biotechnology Co Ltd
Inactive CompaniesBeijing Jindike Bio-technology Research Institute
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A